Window-of-opportunity trials in the preoperative setting: Insights into drug development for estrogen receptor-positive breast cancer

Matthew P. Goetz; Vera J. Suman

doi:10.1200/JCO.2015.66.2312

Window-of-opportunity trials in the preoperative setting: Insights into drug development for estrogen receptor-positive breast cancer

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1970-1972
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	34
Issue number	17
DOIs	https://doi.org/10.1200/JCO.2015.66.2312
State	Published - Jun 10 2016

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2015.66.2312

Cite this

@article{229fd0e5c0894026be78a773e8d6c989,

title = "Window-of-opportunity trials in the preoperative setting: Insights into drug development for estrogen receptor-positive breast cancer",

author = "Goetz, {Matthew P.} and Suman, {Vera J.}",

note = "Funding Information: Supported by Grant No. CA15083-40A2 (M.P.G. and V.J.S.), Mayo Clinic Breast SPORE Grant No. P50CA 116201-10 (M.P.G. and V.J.S.), and funding from the Mayo Clinic Center for Individualized Medicine (M.P.G., V.J.S.), the George M. Eisenberg Foundation for Charities (M.P.G.), Regis Foundation (M.P.G.), and Prospect Creek Foundation (M.P.G.). Eli Lilly, Pfizer",

year = "2016",

month = jun,

day = "10",

doi = "10.1200/JCO.2015.66.2312",

language = "English (US)",

volume = "34",

pages = "1970--1972",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "17",

}

TY - JOUR

T1 - Window-of-opportunity trials in the preoperative setting

T2 - Insights into drug development for estrogen receptor-positive breast cancer

AU - Goetz, Matthew P.

AU - Suman, Vera J.

N1 - Funding Information: Supported by Grant No. CA15083-40A2 (M.P.G. and V.J.S.), Mayo Clinic Breast SPORE Grant No. P50CA 116201-10 (M.P.G. and V.J.S.), and funding from the Mayo Clinic Center for Individualized Medicine (M.P.G., V.J.S.), the George M. Eisenberg Foundation for Charities (M.P.G.), Regis Foundation (M.P.G.), and Prospect Creek Foundation (M.P.G.). Eli Lilly, Pfizer

PY - 2016/6/10

Y1 - 2016/6/10

UR - http://www.scopus.com/inward/record.url?scp=84971602443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971602443&partnerID=8YFLogxK

U2 - 10.1200/JCO.2015.66.2312

DO - 10.1200/JCO.2015.66.2312

M3 - Editorial

C2 - 27001589

AN - SCOPUS:84971602443

SN - 0732-183X

VL - 34

SP - 1970

EP - 1972

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 17

ER -

Window-of-opportunity trials in the preoperative setting: Insights into drug development for estrogen receptor-positive breast cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this